Novamind Ventures

Novamind Ventures

Novamind Ventures is a toronto-based psychedelic therapy research and development company founded in 2019 by Yaron Conforti.

All edits by  Jason D. Rowley 

Edits on 3 Aug, 2020
Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Infobox (-1 properties)
Infobox
Is a
Investor
Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Investor
Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Infobox (+2 properties)
Infobox
CEO
Yaron Conforti
Founder
Yaron Conforti
Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Timeline (+1 events) (+574 characters)
Timeline

March 30, 2020

Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S.

Novamind Ventures closed acquisitions of Cedar Psychiatry LLC ("Cedar Psychiatry"),a specialized provider of ketamine-assisted psychotherapy and Cedar Clinical Research LLC ("Cedar Clinical Research"), a dedicated research center focused on psychedelic medicines, both based near Salt Lake City, Utah.

Total consideration paid by Novamind for the Cedar Acquisitions was CAN$3.05 million, consisting of CAN$1 million cash and CAN$2.05 million in Novamind common shares.

Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Description (+67 characters)
Topic thumbnail

Novamind Ventures

Toronto-based psychedelic therapy research and development company.

Jason D. Rowley
Jason D. Rowley edited on 3 Aug, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Legal name
Novamind Ventures, Inc.
Edits on 9 Jul, 2020
Jason D. Rowley
Jason D. Rowley edited on 9 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Psilocybin
Jason D. Rowley
Jason D. Rowley edited on 9 Jul, 2020
Edits made to:
Infobox (+5/--1 properties)
Article (+557 characters)
Article

Novamind was founded in May 2019 in Toronto, Canada. Ongoing clinical trials approved by the U.S. Food and Drug Administration (“FDA”) are currently evaluating the safety and efficacy of MDMA-assisted psychotherapy (to treat PTSD) and psilocybin-assisted psychotherapy (to treat depression), and if approved, will require specialized infrastructure to facilitate patient treatment. Novamind seeks to accelerate research and innovation in psychedelic medicine by investing in the people, science and technology required for a regulated psychedelics industry.

Infobox
Date incorporated
May 2019
Company status
Active
Founded date
May 2019
Industry
MDMA
Location
Toronto
Jason D. Rowley"Approved suggestion from source: https://twitter.com/novamind_inc"
Jason D. Rowley approved a suggestion from Golden's AI on 9 Jul, 2020
Edits made to:
Topic thumbnail

Novamind Ventures

Toronto-based psychedelic therapy research and development company.

Jason D. Rowley"Approved suggestion #858591 from source: https://novamind.ca/"
Jason D. Rowley approved a suggestion from Golden's AI on 9 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Jason D. Rowley"Approved suggestion #858590 from source: https://novamind.ca/"
Jason D. Rowley approved a suggestion from Golden's AI on 9 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Jason D. Rowley
Jason D. Rowley edited on 9 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Jason D. Rowley"Initial creation data"
Jason D. Rowley edited on 9 Jul, 2020
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Company
Jason D. Rowley"Created via: Web app"
Jason D. Rowley created this topic on 9 Jul, 2020
Edits made to:
Topic thumbnail

 Novamind Ventures

Toronto-based psychedelic therapy research and development company.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.